CoChat

Comparison of demographic factors and cardiovascular risk factor control among U.S. adults with type 2 diabetes by insulin treatment classification

Open access
Wong, Kalina, Glovaci, Diana, Malik, Shaista, Franklin, Stanley S., Wygant, Gail, Iloeje, Uchenna, Kan, Hongjun, Wong, Nathan D. · 2012 · Journal of Diabetes and its Complications
Cited by 62

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Aims Data on glucose and cardiovascular disease (CVD) risk factor control among persons with type 2 diabetes mellitus (DM) according to insulin treatment status are lacking. We examined DM control, risk factors, and comorbidities among U.S. persons according to insulin treatment status. Methods In the U.S. National Health and Nutrition Examination Surveys 2003–2006, we examined in 10,637 adults aged ≥30 with type 2 DM the extent of control of A1c, LDL-C, HDL-C, triglycerides, and blood pressure (BP) and composite goal attainment by insulin use status. Results 6.6% (n=889, projected to 14.3 million) had type 2 DM; of these, 22.9% were insulin users and 57.2% were treated only by other diabetes medications. Overall, 58.2% had an A1c<7% (53 mmol/mol) (insulin users 33.1%, non-insulin treated 66.1%, and 77.9% of those not on medication, p<0.0001). Overall, 44.2% were at a BP goal of <130/80 mmHg, 43.8% had an LDL-C<100 mg/dl (2.6 mmol/L), and 13.9% a BMI<25 kg/m2. Only 10.2% were simultaneously at A1c, LDL, and BP goals (5.4% of those on insulin). Conclusions U.S. adults with type 2 DM, especially those treated with insulin remain inadequately controlled for A1c and CVD risk factors and have a high prevalence of comorbidities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jdiacomp.2012.03.006

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 21

  1. Ahmann, 2007, Guidelines and performance measures for diabetes, The American Journal of Managed Care, 13, S41
  2. American Diabetes Association, 2011, Executive summary: standards for medical care in diabetes—2011, Diabetes Care, 34, s4
  3. Bertoni, 2008, Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study, Journal of Diabetes and its Complications, 22, 1, 10.1016/j.jdiacomp.2006.10.003 · DOI
  4. Bouchi, 2010, Association of albuminuria and reduced estimated glomerular filtration rate with incident stroke and coronary artery disease in patients with type 2 diabetes, Hypertension Research: Official Journal of the Japanese Society of Hypertension, 10.1038/hr.2010.170 · DOI
  5. Breen, 2011, Effects of insulin on the vasculature, Current Vascular Pharmacology, 9, 321, 10.2174/157016111795495558 · doi:10.2174/157016111795495558
  6. Cheung, 2009, Diabetes prevalence and therapeutic target achievement in the United States, 1999–2006, The American Journal of Medicine, 122, 443, 10.1016/j.amjmed.2008.09.047 · DOI · Paper page
  7. Chobanian, 2003, The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, JAMA: The Journal of The American Medical Association, 289, 2560, 10.1001/jama.289.19.2560 · DOI · Paper page
  8. Hansson, 1998, Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group, Lancet, 351, 1755, 10.1016/S0140-6736(98)04311-6 · DOI · Paper page
  9. Imperatore, 2004, Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971–2000, American Journal of Epidemiology, 160, 531, 10.1093/aje/kwh232 · DOI · Paper page
  10. Kemp, 2005, Glucose, lipid, and blood pressure control in Australian adults with type 2 diabetes, Diabetes Care, 28, 1490, 10.2337/diacare.28.6.1490 · DOI · Paper page
  11. Koopman, 2005, Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000, Annals of Family Medicine, 3, 60, 10.1370/afm.214 · DOI · Paper page
  12. Levey, 1999, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation, Annals of Internal Medicine, 130, 461, 10.7326/0003-4819-130-6-199903160-00002 · DOI · Paper page
  13. Malik, 2007, Untreatment of cardiovascular risk factors among persons with diabetes in the United States, Diabetes Research and Clinical Practice, 77, 126, 10.1016/j.diabres.2006.10.016 · DOI
  14. National Kidney Foundation, 2002, K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation, s198
  15. Nichols, 2000, Achieving further glycemic control in type 2 diabetes mellitus, The Western Journal of Medicine, 173, 175, 10.1136/ewjm.173.3.175 · doi:10.1136/ewjm.173.3.175
  16. Rodbard, 2007, American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus, Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 13, 1, 10.4158/EP.13.S1.1 · DOI · Paper page
  17. Saydah, 2003, Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes, JAMA: the Journal of the American Medical Association, 26, 2713
  18. 2008, Effects of intensive glucose lowering in type 2 diabetes, The New England Journal of Medicine, 358, 2545, 10.1056/NEJMoa0802743 · DOI · Paper page
  19. Vijan, 2004, Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians, Annals of Internal Medicine, 140, 650, 10.7326/0003-4819-140-8-200404200-00013 · DOI · Paper page
  20. Wong, 2007, High prevalence and treatment rates, but inadequate control of hypertension in U.S. persons in 2003–2004 with cardiovascular disease comorbidities, Archives of Internal Medicine, 167, 2437, 10.1001/archinte.167.22.2431 · DOI · Paper page
  21. Zeber, 2010, Cardiovascular disease in type 2 diabetes: attributable risk due to modifiable risk factors, Canadian Family Physician Medecin de Famille Canadien, 56, e302

Cited by

See all 62

Metadata

Authors
Wong, K., Glovaci, D., Malik, S., Franklin, S. S., Wygant, G., Iloeje, U., Kan, H., & Wong, N. D.
Venue
Journal of Diabetes and its Complications
Publisher
Elsevier BV
Published
2012-05
Volume
26
Issue
3
Pages
169-174
ISSN
  • 0891-6632 (ISSN-L)
  • 1056-8727
OpenAlex
W2100758175
Cited by
62
References
10
FWCI
4.60
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
Bristol Myers-Squibb

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of demographic factors and cardiovascular risk factor control among U.S. adults with type 2 diabetes by insulin treatment classification. https://app.cochat.ai/papers/10.1016/j.jdiacomp.2012.03.006
The paper
Wong, K., Glovaci, D., Malik, S., Franklin, S. S., Wygant, G., Iloeje, U., Kan, H., & Wong, N. D. (2012). Comparison of demographic factors and cardiovascular risk factor control among U.S. adults with type 2 diabetes by insulin treatment classification. Journal of Diabetes and its Complications. https://doi.org/10.1016/j.jdiacomp.2012.03.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.